Leadership Team
Executive Team
Business Teams
Latest Maxim Group News
Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today
June 9, 2023
Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today
June 9, 2023
Beneficient – a Financial Technology-Enabled Institution – Lists Shares Upon Successful Merger
Beneficient (“Ben,” “Beneficient” or the “Company”), a technology-enabled platform providing liquidity and related trust and
June 9, 2023